Trial Profile
Modulation of Breast Cancer Risk Biomarkers in Premenopausal Women by High Dose Omega-3 Fatty Acids.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Breast cancer
- Focus Pharmacodynamics
- 01 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 24 Sep 2012 Planned End Date changed from 1 Nov 2012 to 1 Nov 2013 as reported by ClinicalTrials.gov record.
- 24 Sep 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.